Temat: "Drug Therapy, Combination" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer.
Autorzy:: Suo D; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Gao X; The clinical Laboratory Center, Hainan General Hospital, Hainan affiliated Hospital of Hainan Medical University, Haikou, 570311, China.
Chen Q; Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Zeng T; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Zhan J; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Li G; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Zheng Y; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Zhu S; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Yun J; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Guan XY; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.; Department of Clinical Oncology, The University of Hongkong, Hong Kong, China.
Li Y; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Apr 08; Vol. 43 (1), pp. 106. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:: Journal Article
MeSH Terms:: CD8-Positive T-Lymphocytes*/metabolism
Stomach Neoplasms*/genetics
Stomach Neoplasms*/metabolism
Humans ; Up-Regulation ; Immune Evasion ; Drug Therapy, Combination ; HSP110 Heat-Shock Proteins/metabolism ; AlkB Homolog 5, RNA Demethylase/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Real-world performance of indobufen versus aspirin after percutaneous coronary intervention: insights from the ASPIRATION registry.
Autorzy:: Dai C; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.; Shanghai Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.
Liu M; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.; Shanghai Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.
Yang Z; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.; Shanghai Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.
Li Y; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.; Shanghai Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.
Zhou Y; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.; Shanghai Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.
Lu D; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.; Shanghai Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.
Xia Y; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.; Shanghai Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.
Chen A; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.; Shanghai Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.
Li C; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.; Shanghai Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.
Lu H; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.; Shanghai Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.
Dai Y; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.; Shanghai Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.
Ma J; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.; Shanghai Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China.
Chen Z; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai, 200032, China. .; National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China. .; Shanghai Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China. .
Qian J; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai, 200032, China. .; National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China. .; Shanghai Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China. .
Ge J; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai, 200032, China. .; National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China. .; Shanghai Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai, 200032, China. .; Pokaż więcej
Źródło:: BMC medicine [BMC Med] 2024 Apr 02; Vol. 22 (1), pp. 148. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Clinical Trial; Journal Article
MeSH Terms:: Acute Coronary Syndrome*/drug therapy
Acute Coronary Syndrome*/surgery
Isoindoles*
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/methods
Phenylbutyrates*
Humans ; Aspirin/adverse effects ; Drug Therapy, Combination ; Hemorrhage/chemically induced ; Hemorrhage/epidemiology ; Platelet Aggregation Inhibitors/adverse effects ; Registries ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: MFSynDCP: multi-source feature collaborative interactive learning for drug combination synergy prediction.
Autorzy:: Dong Y; School of Software, Taiyuan University of Technology, Taiyuan, Shanxi, China. .
Chang Y; School of Software, Taiyuan University of Technology, Taiyuan, Shanxi, China.
Wang Y; School of Software, Taiyuan University of Technology, Taiyuan, Shanxi, China.
Han Q; School of Software, Taiyuan University of Technology, Taiyuan, Shanxi, China.
Wen X; School of Software, Taiyuan University of Technology, Taiyuan, Shanxi, China.
Yang Z; School of Software, Taiyuan University of Technology, Taiyuan, Shanxi, China.
Zhang Y; School of Software, Taiyuan University of Technology, Taiyuan, Shanxi, China.
Qiang Y; College of Computer Science and Technology (College of Data Science), Taiyuan University of Technology, Taiyuan, Shanxi, China. .
Wu K; School of Computing, University of Leeds, Leeds, West Yorkshire, UK.
Fan X; Information Management Department, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China.
Ren X; Information Management Department, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China.; Pokaż więcej
Źródło:: BMC bioinformatics [BMC Bioinformatics] 2024 Apr 01; Vol. 25 (1), pp. 140. Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:: Journal Article
MeSH Terms:: Benchmarking*
Simulation Training*
Drug Combinations ; Drug Therapy, Combination ; Cell Line

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Variables associated with antibiotic treatment tolerance in patients with Mycobacterium avium complex pulmonary disease.
Autorzy:: Marmor M; Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA, United States of America. .
Sharifi H; Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA, United States of America.
Jacobs S; Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA, United States of America.
Fazeli K; Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA, United States of America.
Ruoss S; Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA, United States of America.; Pokaż więcej
Źródło:: Respiratory research [Respir Res] 2024 Mar 11; Vol. 25 (1), pp. 123. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:: Review; Journal Article
MeSH Terms:: Mycobacterium avium-intracellulare Infection*/diagnosis
Mycobacterium avium-intracellulare Infection*/drug therapy
Mycobacterium avium-intracellulare Infection*/microbiology
Lung Diseases*/diagnosis
Lung Diseases*/drug therapy
Lung Diseases*/epidemiology
Liver Diseases*
Humans ; Mycobacterium avium Complex ; Retrospective Studies ; Drug Therapy, Combination ; Anti-Bacterial Agents/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques.
Autorzy:: Lim SY; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Lee J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Osuna CE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Vikhe P; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Schalk DR; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Chen E; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Fray E; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Kumar M; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Schultz-Darken N; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Rakasz E; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Capuano S; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Ladd RA; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Gil HM; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Evans DT; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Jeng EK; Altor Biosciences, Miramar, FL 33027, USA.
Seaman M; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Martin M; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Van Dorp C; Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Perelson AS; Los Alamos National Laboratory, Los Alamos, NM 87545, USA.; Santa Fe Institute, Santa Fe, NM 87501, USA.
Wong HC; Altor Biosciences, Miramar, FL 33027, USA.
Siliciano JD; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Siliciano R; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.; Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Safrit JT; ImmunityBio, Culver City, CA 90232, USA.
Nixon DF; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Soon-Shiong P; ImmunityBio, Culver City, CA 90232, USA.
Nussenzweig M; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.; Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10065, USA.
Whitney JB; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.; Department of Biology, Boston College, Chestnut Hill, MA 02467, USA.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2024 Mar 08; Vol. 383 (6687), pp. 1104-1111. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:: Journal Article
MeSH Terms:: Anti-Retroviral Agents*/therapeutic use
Anti-Retroviral Agents*/pharmacology
Simian Acquired Immunodeficiency Syndrome*/drug therapy
Simian Acquired Immunodeficiency Syndrome*/therapy
Simian Immunodeficiency Virus*
Recombinant Fusion Proteins*/administration & dosage
Recombinant Fusion Proteins*/pharmacology
Animals ; Humans ; Broadly Neutralizing Antibodies/administration & dosage ; CD8-Positive T-Lymphocytes/virology ; Immunotherapy ; Macaca mulatta ; Viral Load ; Remission Induction ; Drug Therapy, Combination

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: The prevalence, clinical reasoning and impact of non-standard anti-tuberculosis regimens at the initial prescription.
Autorzy:: Chen RT; Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan.
Liu CY; Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan.
Lin SY; College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, No 7, Chung Shan South Road, Taipei, Taiwan.
Shu CC; College of Medicine, National Taiwan University, Taipei, Taiwan. .; Department of Internal Medicine, National Taiwan University Hospital, No 7, Chung Shan South Road, Taipei, Taiwan. .
Sheng WH; College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, No 7, Chung Shan South Road, Taipei, Taiwan.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 07; Vol. 14 (1), pp. 5631. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: Tuberculosis*/drug therapy
Tuberculosis*/epidemiology
Tuberculosis, Multidrug-Resistant*/drug therapy
Gout*/drug therapy
Humans ; Antitubercular Agents/therapeutic use ; Prevalence ; Drug Therapy, Combination ; Clinical Reasoning

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: The deleterious effects of sofosbuvir and ribavirin (antiviral drugs against hepatitis C virus) on different body systems in male albino rats regarding reproductive, hematological, biochemical, hepatic, and renal profiles and histopathological changes.
Autorzy:: Ali RA; Zoology Department, Faculty of Science, South Valley University, Qena, Egypt.
Awadalla EA; Zoology Department, Faculty of Science, Aswan University, Aswan, Egypt.
Amin YA; Department of Theriogenology, Faculty of Veterinary Medicine, Aswan University, Aswan, Egypt. .
Fouad SS; Qena University Hospital, South Valley University, Qena, Egypt.
Ahmed MAB; Department of Anatomy, Faculty of Medicine, South Valley University, Qena, Egypt.
Hassan MH; Department of Medical Biochemistry, Faculty of Medicine, South Valley University, Qena, Egypt.
Abdel-Kahaar E; Department of Medical Pharmacology, Faculty of Medicine, South Valley University, Qena, Egypt.; Institute of Clinical Pharmacology, Medical Faculty Mannheim, Ruprecht-Karls-University, Heidelberg, Germany.
Abdel-Aziz RH; Department of Medical Physiology, Faculty of Medicine, South Valley University, Qena, Egypt.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 07; Vol. 14 (1), pp. 5682. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis C, Chronic*/drug therapy
Pancreatitis*/chemically induced
Humans ; Adult ; Child ; Male ; Animals ; Rats ; Antiviral Agents/adverse effects ; Sofosbuvir/adverse effects ; Ribavirin/therapeutic use ; Hepacivirus/genetics ; Acute Disease ; Treatment Outcome ; Drug Therapy, Combination ; Semen ; Sperm Motility ; Liver Cirrhosis/complications ; Lipase/genetics ; Genotype

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Dolutegravir + Lamivudine vs. Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Very-Low-Level HIV-1 Replication through 144 Weeks in the GEMINI-1 and GEMINI-2 Studies.
Autorzy:: Underwood M; ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC 27701, USA.
Urbaityte R; GSK, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK.
Wang R; ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC 27701, USA.
Horton J; Parexel, 2520 Meridian Parkway, Durham, NC 27713, USA.
Oyee J; GSK, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK.
Wynne B; ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC 27701, USA.
Fox D; ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC 27701, USA.
Jones B; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK.
Man C; ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC 27701, USA.
Sievers J; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Mar 06; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
HIV-1*
HIV Seropositivity*
Oxazines*
Piperazines*
Pyridones*
Adult ; Humans ; Lamivudine/therapeutic use ; Emtricitabine/therapeutic use ; Tenofovir/therapeutic use ; Drug Therapy, Combination ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Viral Load ; Virus Replication

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Efficacy and safety of venlafaxine hydrochloride combined with tandospirone citrate for patients with vascular depression accompanied by somatic symptoms: An open-labeled randomized control trial.
Autorzy:: Chen H; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Lin Y; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.; Department of Neurology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, China.
Zhao Z; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Lin T; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Lin Q; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Chen X; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Wu W; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Zeng G; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Wu S; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Liu N; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Chen H; Gynecology Department, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Chen R; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Xiao Y; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.; Pokaż więcej
Źródło:: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Mar; Vol. 30 (3), pp. e14650.
Typ publikacji:: Journal Article; Randomized Controlled Trial
MeSH Terms:: Anti-Anxiety Agents*
Isoindoles*
Medically Unexplained Symptoms*
Piperazines*
Pyrimidines*
Vascular Depression*
Humans ; Citrates ; Depression/drug therapy ; Selective Serotonin Reuptake Inhibitors ; Serotonin ; Treatment Outcome ; Venlafaxine Hydrochloride/therapeutic use ; Drug Therapy, Combination/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Clinical outcomes and risk factors for immune recovery and all-cause mortality in Latin Americans living with HIV with virological success: a retrospective cohort study.
Autorzy:: Castillo-Rozas G; Laboratory of Molecular and Cellular Virology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile.; HIV/AIDS Workgroup, Faculty of Medicine, University of Chile, Santiago, Chile.
Tu S; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Luz PM; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Mejia F; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú.
Sierra-Madero J; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México.
Rouzier V; Groupe Haitien d'Etudes du Sarcome de Kaposi et des Infections Opportunistes, Port-au-Prince, Haiti.
Shepherd BE; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Cortes CP; HIV/AIDS Workgroup, Faculty of Medicine, University of Chile, Santiago, Chile.; Department of Internal Medicine, Faculty of Medicine, University of Chile, Santiago, Chile.; Hospital Clínico San Borja Arriarán & Fundación Arriarán, Santiago, Chile.; Millenium Institute on Immunology and Immunotherapy, Santiago, Chile.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26214.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*
Acquired Immunodeficiency Syndrome*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Male ; Retrospective Studies ; Risk Factors ; Drug Therapy, Combination ; CD4 Lymphocyte Count ; Viral Load ; Antiretroviral Therapy, Highly Active

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study.
Autorzy:: Liu X; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Lv X; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Peng Y; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Wang J; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Lei J; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Tang C; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Luo S; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Mai W; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Cai Y; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Fan Q; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Liu C; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Zhang L; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China. .; Pokaż więcej
Źródło:: BMC neurology [BMC Neurol] 2024 Mar 01; Vol. 24 (1), pp. 81. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Ischemic Attack, Transient*/drug therapy
Ischemic Attack, Transient*/epidemiology
Ischemic Stroke*/drug therapy
Stroke*/drug therapy
Phenylbutyrates*
Isoindoles*
Humans ; Aspirin ; Clopidogrel/therapeutic use ; Platelet Aggregation Inhibitors/adverse effects ; Prospective Studies ; Hemorrhage/chemically induced ; Drug Therapy, Combination ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Efficacy and tolerability of adjunctive lacosamide in patients aged <4 years with focal seizures.
Autorzy:: Makedonska I; Municipal Non-profit Enterprise City Children's Clinical Hospital #6 of Dnipro City Council, Dnipro, Ukraine.
Ng YT; Baylor College of Medicine/The Children's Hospital of San Antonio, San Antonio, Texas, USA.
Beller C; UCB Pharma, Morrisville, North Carolina, USA.
Bozorg A; UCB Pharma, Morrisville, North Carolina, USA.
Csikós J; UCB Pharma, Monheim am Rhein, Germany.
McClung C; UCB Pharma, Morrisville, North Carolina, USA.
Moeltgen H; UCB Pharma, Monheim am Rhein, Germany.
Farkas MK; Pediatric Center, MTA Center of Excellence, Semmelweis University, Budapest, Hungary.; Pokaż więcej
Corporate Authors:: SP0967 Study Group
Źródło:: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Mar; Vol. 11 (3), pp. 768-779. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Anticonvulsants*/adverse effects
Epilepsies, Partial*/drug therapy
Adult ; Child ; Humans ; Child, Preschool ; Lacosamide/adverse effects ; Reproducibility of Results ; Acetamides/adverse effects ; Drug Therapy, Combination ; Dose-Response Relationship, Drug ; Treatment Outcome ; Seizures/drug therapy ; Seizures/chemically induced

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta-analysis.
Autorzy:: Kishi T; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Sakuma K; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Hatano M; Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Matsuda Y; Department of Psychiatry, Jikei University School of Medicine, Minato, Tokyo, Japan.
Esumi S; Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Hyogo, Japan.
Miyake N; Department of Neuropsychiatry, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Miura I; Department of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan.
Hori H; Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Kato M; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan.
Iwata N; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.; Pokaż więcej
Źródło:: Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2024 Mar; Vol. 44 (1), pp. 216-220. Date of Electronic Publication: 2023 Aug 30.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Depressive Disorder, Major*/drug therapy
Adult ; Humans ; Japan ; Antidepressive Agents/therapeutic use ; Drug Therapy, Combination ; Randomized Controlled Trials as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Efficacy of empagliflozin as adjunctive therapy to citalopram in major depressive disorder: a randomized double-blind, placebo-controlled clinical trial.
Autorzy:: Zandifar A; Social Determinants of Health Research Center, Alborz University of Medical Sciences, Karaj, Iran.; Department of Psychiatry, Imam Hossein Hospital, Alborz University of Medical Sciences, Karaj, Alborz, Iran.
Panahi M; Faculty of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Badrfam R; Department of Psychiatry, Imam Hossein Hospital, Alborz University of Medical Sciences, Karaj, Alborz, Iran. .
Qorbani M; Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.; Chronic Diseases Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.; Pokaż więcej
Źródło:: BMC psychiatry [BMC Psychiatry] 2024 Feb 26; Vol. 24 (1), pp. 163. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Benzhydryl Compounds*
Citalopram*/therapeutic use
Depressive Disorder, Major*/drug therapy
Glucosides*
Humans ; Antidepressive Agents/therapeutic use ; Double-Blind Method ; Drug Therapy, Combination ; Treatment Outcome ; Adolescent ; Young Adult ; Adult ; Middle Aged

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis.
Autorzy:: Sohn M; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Republic of Korea.
Lim S; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Republic of Korea.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 23; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:: Meta-Analysis; Journal Article; Review
MeSH Terms:: Atherosclerosis*
Peripheral Arterial Disease*
Humans ; Cilostazol ; Phosphodiesterase 3 Inhibitors ; Platelet Aggregation Inhibitors ; Cholesterol, HDL ; Phosphoric Diester Hydrolases ; Biology ; Tetrazoles ; Drug Therapy, Combination

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Effect of multidrug therapy on the prognosis of Mycobacterium avium complex pulmonary disease.
Autorzy:: Ushiki A; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan. .
Tanaka S; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Yamanaka M; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Akahane J; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Ikuyama Y; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Komatsu M; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Sonehara K; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Ichiyama T; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Wada Y; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Tateishi K; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Kitaguchi Y; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Hanaoka M; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 23; Vol. 14 (1), pp. 4438. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:: Journal Article
MeSH Terms:: Mycobacterium avium-intracellulare Infection*/microbiology
Lung Diseases*/microbiology
Humans ; Male ; Middle Aged ; Mycobacterium avium Complex ; Retrospective Studies ; Drug Therapy, Combination ; Leprostatic Agents/pharmacology ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: SynerGNet: A Graph Neural Network Model to Predict Anticancer Drug Synergy.
Autorzy:: Liu M; Division of Electrical and Computer Engineering, Louisiana State University, Baton Rouge, LA 70803, USA.
Srivastava G; Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA.
Ramanujam J; Division of Electrical and Computer Engineering, Louisiana State University, Baton Rouge, LA 70803, USA.; Center for Computation and Technology, Louisiana State University, Baton Rouge, LA 70803, USA.
Brylinski M; Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA.; Center for Computation and Technology, Louisiana State University, Baton Rouge, LA 70803, USA.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2024 Feb 21; Vol. 14 (3). Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:: Journal Article
MeSH Terms:: Artificial Intelligence*
Antineoplastic Agents*/pharmacology
Humans ; Neural Networks, Computer ; Combined Modality Therapy ; Drug Therapy, Combination

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
Autorzy:: Semitala FC; Makerere University, Department of Medicine, College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda.; Makerere University Joint AIDS Program, Kampala Uganda.
Kadota JL; Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
Musinguzi A; Infectious Diseases Research Collaboration, Kampala, Uganda.
Welishe F; Infectious Diseases Research Collaboration, Kampala, Uganda.
Nakitende A; Infectious Diseases Research Collaboration, Kampala, Uganda.
Akello L; Infectious Diseases Research Collaboration, Kampala, Uganda.
Kunihira Tinka L; Infectious Diseases Research Collaboration, Kampala, Uganda.
Nakimuli J; Infectious Diseases Research Collaboration, Kampala, Uganda.
Ritar Kasidi J; Infectious Diseases Research Collaboration, Kampala, Uganda.
Bishop O; Infectious Diseases Research Collaboration, Kampala, Uganda.
Nakasendwa S; Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.
Baik Y; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Patel D; The Better Lab and Department of Surgery, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
Sammann A; The Better Lab and Department of Surgery, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
Nahid P; Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
Belknap R; Denver Health and Hospital Authority and Division of Infectious Diseases, Department of Medicine, University of Colorado, Denver, Colorado, United States of America.
Kamya MR; Makerere University, Department of Medicine, College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda.
Handley MA; Center for Vulnerable Populations, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America.
Phillips PP; Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
Katahoire A; Child Health and Development Center, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Berger CA; Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
Kiwanuka N; Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.
Katamba A; Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.
Dowdy DW; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Cattamanchi A; Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.; Division of Pulmonary Diseases and Critical Care Medicine, University of California Irvine, Irvine, California, United States of America.; Pokaż więcej
Źródło:: PLoS medicine [PLoS Med] 2024 Feb 20; Vol. 21 (2), pp. e1004356. Date of Electronic Publication: 2024 Feb 20 (Print Publication: 2024).
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Tuberculosis*/drug therapy
Tuberculosis*/prevention & control
Latent Tuberculosis*/drug therapy
HIV Infections*/complications
HIV Infections*/drug therapy
Rifampin/*analogs & derivatives
Humans ; Isoniazid/adverse effects ; Antitubercular Agents/adverse effects ; Uganda ; Drug Therapy, Combination

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Several first-line anti-hypertensives act on fibrosarcoma progression and PD1ab blockade therapy.
Autorzy:: Sun J; Department of Orthopaedics, The First Affiliated Hospital of Jishou University, The People's Hospital of Xiangxi Autonomous Prefecture, Jishou, China.
Zhang C; Department of Jishou University, Jishou, China.
Su X; Department of Jishou University, Jishou, China.
Zhou H; Department of Medicine, Taizhou University, Zhejiang, China.
Zhou S; Department of Medicine, Taizhou University, Zhejiang, China.
Jiang M; Department of Medicine, Taizhou University, Zhejiang, China.
Fang B; Department of Medicine, Taizhou University, Zhejiang, China. .; Pokaż więcej
Źródło:: Journal of orthopaedic surgery and research [J Orthop Surg Res] 2024 Feb 19; Vol. 19 (1), pp. 147. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:: Journal Article
MeSH Terms:: Hypertension*/drug therapy
Fibrosarcoma*/drug therapy
Humans ; Antihypertensive Agents/therapeutic use ; Losartan/pharmacology ; Losartan/therapeutic use ; Captopril/pharmacology ; Captopril/therapeutic use ; Spironolactone/therapeutic use ; Furosemide/therapeutic use ; CD8-Positive T-Lymphocytes ; Hydrochlorothiazide/therapeutic use ; Drug Therapy, Combination ; Verapamil/pharmacology ; Verapamil/therapeutic use ; Solute Carrier Family 12, Member 3

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Association between failed eradication of 7-day triple therapy for Helicobacter pylori and untreated dental caries in Japanese adults.
Autorzy:: Iwai K; Department of Community Oral Health, School of Dentistry, Asahi University, 1851-1 Hozumi, Mizuho, Gifu, 501-0296, Japan.
Azuma T; Department of Community Oral Health, School of Dentistry, Asahi University, 1851-1 Hozumi, Mizuho, Gifu, 501-0296, Japan.
Yonenaga T; Department of Community Oral Health, School of Dentistry, Asahi University, 1851-1 Hozumi, Mizuho, Gifu, 501-0296, Japan.
Sasai Y; Department of Community Oral Health, School of Dentistry, Asahi University, 1851-1 Hozumi, Mizuho, Gifu, 501-0296, Japan.
Watanabe K; Asahi University Hospital, 3-23 Hashimoto-Cho, Gifu, Gifu, 500-8523, Japan.
Obora A; Asahi University Hospital, 3-23 Hashimoto-Cho, Gifu, Gifu, 500-8523, Japan.
Deguchi F; Asahi University Hospital, 3-23 Hashimoto-Cho, Gifu, Gifu, 500-8523, Japan.
Kojima T; Asahi University Hospital, 3-23 Hashimoto-Cho, Gifu, Gifu, 500-8523, Japan.
Tomofuji T; Department of Community Oral Health, School of Dentistry, Asahi University, 1851-1 Hozumi, Mizuho, Gifu, 501-0296, Japan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 19; Vol. 14 (1), pp. 4043. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:: Journal Article
MeSH Terms:: Helicobacter pylori*
Dental Caries*/drug therapy
Helicobacter Infections*/complications
Helicobacter Infections*/drug therapy
Anti-Infective Agents*/therapeutic use
Adult ; Humans ; Anti-Bacterial Agents/therapeutic use ; Cross-Sectional Studies ; Japan/epidemiology ; Drug Therapy, Combination ; Treatment Outcome ; Clarithromycin/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Drug Therapy, Combination"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język